Iron Triangle Partners LP - Q2 2020 holdings

$397 Million is the total value of Iron Triangle Partners LP's 24 reported holdings in Q2 2020. The portfolio turnover from Q1 2020 to Q2 2020 was - .

 Value Shares↓ Weighting
HOLX NewHOLOGIC INC$28,500,000500,000
+100.0%
7.18%
IQV NewIQVIA HLDGS INC$19,519,000137,577
+100.0%
4.92%
BMY NewBRISTOL-MYERS SQUIBB COcall$11,760,000200,000
+100.0%
2.96%
NVST NewENVISTA HOLDINGS CORPORATION$10,545,000500,000
+100.0%
2.66%
INSP NewINSPIRE MED SYS INC$10,099,000116,054
+100.0%
2.54%
SGRY NewSURGERY PARTNERS INC$7,829,000676,652
+100.0%
1.97%
RPRX NewROYALTY PHARMA PLC$4,855,000100,000
+100.0%
1.22%
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2020-08-14
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
HORIZON THERAPEUTICS PUB LTD12Q3 20229.0%
GUARDANT HEALTH INC12Q3 20226.1%
CHARLES RIV LABS INTL INC11Q1 20237.8%
SURGERY PARTNERS INC11Q2 20236.4%
ICON PLC10Q3 202311.7%
BOSTON SCIENTIFIC CORP10Q3 20238.9%
NEVRO CORP10Q1 20226.7%
DEXCOM INC10Q3 20237.7%
ABBVIE INC9Q3 20238.1%
ACADIA HEALTHCARE COMPANY IN9Q3 20237.9%

View Iron Triangle Partners LP's complete holdings history.

Latest filings
TypeFiled
13F-HR2024-02-14
13F-HR2023-11-14
13F-HR2023-08-14
13F-HR2023-05-15
13F-HR2023-02-14
13F-HR2022-11-14
13F-HR2022-08-15
13F-HR2022-05-16
13F-HR2022-02-14
13F-HR2021-11-15

View Iron Triangle Partners LP's complete filings history.

Compare quarters

Export Iron Triangle Partners LP's holdings